Our vision is to improve health and quality of life by realizing the full potential of quantitative approaches.
We believe quantitative approaches can achieve much more moving forward.
Over the past decade, the judicious application of quantitative approaches has resulted in meaningful clinical trial efficiency gains, cost reductions, and provided a reliable basis for decision making across all stages of development. There are many unrealized benefits and opportunities to be won.
Pharmetheus harnesses the full potential of quantitative approaches in combination with relevant data and robust assumptions to improve the depth of understanding of a drug’s efficacy and safety, limiting uncertainty, and thereby underpinning its development path.
Our mission is to deliver a full range of efficient and timely model-informed drug development services that support decision making in healthcare.
Through fit-for-purpose approaches, we create a more reliable basis for understanding a drug’s attributes. We reduce uncertainty by delivering trusted analyses in a structured and timely manner, and share best practices with our clients and partners to harness curiosity and generate novel approaches and collaboration. We are committed to scientific advancement and regularly engage at the forefront of development in applied quantitative approaches.
We are devoted to supporting the needs of our clients through the passion for our work. As we do so, we take actions and accountability for the projects entrusted by our clients.
We work as a team, together and with clients, towards achieving a common goal by sharing ideas and skills. As we do so, we learn and develop, as individuals and as a team.
We are true to ourselves and honest with each other and our clients, while considering what is best for patients. As we do so, we also care about how our words and actions may impact others, and accept individual differences.
Pharmetheus leadership team combines industry, academic, and consultancy experience in developing the company and its services.